Deutsche Bank
ARCT icon

Deutsche Bank’s Arcturus Therapeutics ARCT Stock Holding History

Deutsche Bank’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-71
Closed -$3K – 5132
2015
Q4 		$3K Hold
71
– – ﹤0.01% 5107
2015
Q3 		$3K Buy
+71
New +$3.73K ﹤0.01% 5079

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Deutsche Bank's ARCT Position: Q2 2026 in Review

Deutsche Bank reduced its Arcturus Therapeutics (ARCT) stake by 7.6% in Q2 2026, selling an estimated $18.7K and leaving 28,994 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #3270.

Deutsche Bank first reported a position in ARCT in Q4 2013 and has held it in 36 quarters since. The position peaked at $24.4M in Q2 2020. 136 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Deutsche Bank held 28,994 shares of Arcturus Therapeutics worth $195K as of Q2 2026.
  • Deutsche Bank sold 2,370 Arcturus Therapeutics shares in Q2 2026, an estimated $18.7K.
  • Arcturus Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3270 holding.
  • Deutsche Bank first reported a position in Arcturus Therapeutics in Q4 2013 and has held it in 36 quarters since.
  • Deutsche Bank's Arcturus Therapeutics position peaked at $24.4M in Q2 2020.
  • 136 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.